Note: This article provides general information. Diagnosis and treatment require medical care in diabetes or pregnancy, unexplained excessive thirst and urination, rapid weight loss, recurrent hypoglycaemia, childhood, pancreatic disease, or when glucose-lowering medication is used.
What does insulin do, and what is resistance?
Insulin is a pancreatic hormone that helps move glucose from blood into tissues, particularly muscle and fat, and regulates glucose production by the liver. When cells respond less effectively, the pancreas releases more insulin to accomplish the same task.
This compensation can keep blood glucose within range for a time. If insulin production can no longer meet demand, glucose rises and prediabetes or type 2 diabetes may develop. Not every case progresses to diabetes; risk is shaped by genetics, fat distribution, movement, sleep, medicines, and other conditions.
Responsive cell
Glucose is regulated with less insulin.
Reduced response
Muscle, fat, and liver respond less effectively.
Compensation
The pancreas releases more insulin.
Rising glucose
If compensation fails, prediabetes or diabetes may follow.
This sequence does not progress at the same rate in everyone, and lifestyle or treatment can alter it. Prediabetes is not an irreversible threshold.
Can symptoms establish the diagnosis?
Insulin resistance and prediabetes often cause no symptoms. Fatigue, frequent hunger, sugar cravings, difficulty losing weight, or sleepiness after meals are common complaints, but they also occur with inadequate sleep, anaemia, thyroid disease, stress, medicines, and many other conditions.
Acanthosis nigricans—darkened, thickened skin around the neck or underarms—may be associated with insulin resistance, but still requires clinical and laboratory assessment. Self-diagnosis from social-media symptom lists can lead to unnecessary restriction.
How is it assessed?
Research methods that directly measure insulin sensitivity are not routine clinical tests. A1C, fasting plasma glucose, and when appropriate a two-hour 75-g oral glucose-tolerance test are used to assess prediabetes and diabetes risk. Results are interpreted alongside medical history and medicines.
ADA criteria define prediabetes as A1C 5.7–6.4%, fasting plasma glucose 100–125 mg/dL, or two-hour OGTT glucose 140–199 mg/dL. An abnormal diabetes-range result is generally confirmed on another day when symptoms are absent; A1C may be misleading with some anaemias, haemoglobin variants, pregnancy, and kidney conditions.
HOMA-IR is an indirect index calculated from fasting glucose and insulin. It can be useful in research, but thresholds vary with age, sex, ethnicity, laboratory method, and reference population. A single online value should not be treated as a universal diagnostic boundary.
A1C 5.7–6.4%
No fasting required; reliability falls in some clinical conditions.
100–125 mg/dL
A laboratory fasting plasma-glucose measurement.
140–199 mg/dL
An OGTT may identify dysglycaemia missed by fasting tests.
HOMA-IR
There is no single universal diagnostic cut-off.
These values show prediabetes ranges; diabetes uses higher thresholds and appropriate confirmation. Home glucose meters are not diagnostic tests.
What can increase resistance?
Visceral adiposity and fatty liver are important contributors, but insulin resistance is not limited to people at higher body weight. Genetics, age, inactivity, polycystic ovary syndrome, sleep apnoea, insufficient sleep, some medicines, and rarer conditions such as lipodystrophy may also contribute.
Because the condition is multifactorial, blaming carbohydrate or one food is inaccurate. Skeletal muscle is a major site of glucose use; when movement falls and sleep or energy balance deteriorates, risk changes in ways that sugar intake alone cannot explain.
What can nutrition change?
There is no single mandatory insulin-resistance diet. Mediterranean-style, predominantly plant-based, or lower-carbohydrate patterns can work depending on energy needs, preference, and sustainability. Common ground usually includes more vegetables, fruit, legumes, whole grains, nuts, adequate protein, and unsaturated fats, with fewer refined grains, sugary drinks, and energy-dense ultra-processed foods.
Carbohydrate does not have to be eliminated. Portion, fibre, processing, and eating carbohydrate alongside protein, fat, and vegetables all shape the glycaemic response. Improving dietary quality over days and weeks matters more than trying to prevent every isolated insulin rise.
Add fibre to the plate
Use vegetables, legumes, whole grains, and fruit regularly.
Maintain adequate protein
Support lean tissue, particularly during energy restriction.
Reduce liquid sugars
Sugary drinks add rapidly consumed energy with little satiety.
Build a sustainable plan
Choose repeatable meals rather than short-lived prohibition lists.
Why do movement, sleep, and weight belong together?
Muscle can use glucose more effectively during and after exercise. Combining aerobic and resistance exercise may improve insulin sensitivity and preserve muscle more than diet-induced weight loss alone. Exercise has metabolic value even when the scale does not change.
For people with excess adiposity, modest sustainable weight loss can improve liver and muscle insulin sensitivity. Weight loss is not a universal prescription; at low or normal weight, movement, sleep, diet quality, and underlying causes take priority.
Sleep is also a metabolic variable. Controlled studies show that short-term and chronic sleep restriction can reduce insulin sensitivity. Snoring, excessive daytime sleepiness, or resistant hypertension may warrant assessment for sleep apnoea.
Can it fully improve?
Insulin sensitivity is dynamic and can improve substantially in many people through nutrition, movement, sleep, loss of excess adiposity, and medication when indicated. In the Diabetes Prevention Program, intensive lifestyle intervention reduced progression to type 2 diabetes by 58% over three years versus placebo in high-risk adults.
Improvement does not mean genetic susceptibility or future risk has disappeared. A short diet cannot be expected to provide a permanent solution when underlying PCOS, sleep apnoea, medicine effects, or fatty liver remain unaddressed. Follow-up is part of maintaining progress.
Take-home message
Insulin resistance is not the fault of one food; it is a metabolic condition with modifiable contributors.
Assessment relies on appropriate laboratory tests and clinical context, not symptoms or a single online calculation. Diet quality, regular movement, adequate sleep, and weight or medication management when needed can substantially improve insulin sensitivity. The strongest plan addresses the person's risks together rather than banning one macronutrient.
Scientific sources
- American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care, 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. Insulin Resistance & Prediabetes.
- Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine, 2002.
- Gayoso-Diz P, et al. Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population. BMC Endocrine Disorders, 2013.
- Brennan AM, et al. Weight Loss and Exercise Differentially Affect Insulin Sensitivity, Body Composition, Cardiorespiratory Fitness, and Muscle Strength in Older Adults With Obesity. Journals of Gerontology A, 2022.
- Zuraikat FM, et al. Chronic Insufficient Sleep in Women Impairs Insulin Sensitivity Independent of Adiposity Changes. Diabetes Care, 2024.
- Papadaki A, et al. The Effect of the Mediterranean Diet on Metabolic Health: A Systematic Review and Meta-Analysis of Controlled Trials in Adults. Nutrients, 2020.
